Clinical trial
Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact…
NCT00442299 · Universitaire Ziekenhuizen KU Leuven, Other · Suspended
Key facts
| NCT number | NCT00442299 |
|---|---|
| Title | Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function |
| Official title | Phase 1 Study of Albumin Dialysis Using Prometheus in End Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven, Other |
| Status | Suspended |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Device |
| Interventions | Fractionated Plasma Separation and Adsorption (FPSA) |
| Enrollment | 10 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 1, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: